Tej Lalvani: Salubrious Growth
By the turn of 2024, the UK's pharmaceutical market is expected to touch a projected revenue of $31.31 billion. As per industry sources, oncology drugs are expected to be the largest market, with a projected volume of $6.13 billion. The surge in research and development has driven the growth of the country’s pharmaceutical market, which is helping to position the UK as a global hub for innovation. As per Statista, the following six pharma companies have been driving the growth within the UK.
AstraZeneca leads as a global frontrunner in life sciences. The company invests across the full life sciences value chain of the country. In the second place is GlaxoSmithKline. At the heart of the development of its pipeline of vital medicines is the immune system, genetics and advanced technologies. Royalty Pharma is on the third spot, with a portfolio of royalties that entitles it to payments based directly on the top-line sales of many of the industry’s leading therapies. In the fourth position is Roivant, which develops transformative medicines and technologies by building agile, focused companies called Vants. On the fifth spot is Dechra Pharmaceuticals, which is a global specialist in veterinary, with products for dogs, cats, horses, livestock and exotics. And in the sixth position is Hikma Pharmaceuticals, which ranks third as the generic injectable manufacturer in the US and second pharmaceutical company in MENA, and has around 760 products, with 250 projects in the pipeline.
As per industry sources, British pharmaceutical production is forecast to decline, dropping to around €900 million by 2028 from €1.4 billion in 2023, an average annual decrease of 7%. Over the past decade, the UK's pharmaceutical supply has been declining by an average of 6.6% each year since 2013. In 2023, the UK ranked fifth in pharmaceutical production, while Austria surpassed the UK this year, matching the UK's production at €1.4 billion. In terms of production Italy, Spain and Austria ranked second, third and fourth respectively.
Although the above-mentioned pharma companies are leading the pack today in the UK, one of the pharma pioneers of Britain is Vitabiotics Ltd. The company has received twice Queen's Award for Innovation.
Vitabiotics Ltd. was established by Indian-origin Kartar Lalvani, the chairman of the company, in the UK in 1971. Later his former tutor Professor Arnold Beckett joined the firm. Located at 1 Apsley Way, London, the company's current CEO is Tej Lalvani, the son of Kartar Lalvani. After his taking over the reins Vitabiotics has been going from strength to strength, thanks to his able stewardship and his consistent focus on developments and innovations in vitamin and mineral supplements. The company's mission is to 'Empower people to improve their health through innovation in nutritional health care.' With this objective, it has created a leading portfolio of trusted, effective brands. The company has created a unique portfolio of products at the forefront of scientific developments in key sectors, including nutrition and women’s health.
The Lalvanis
Born to a Sindhi Sikh family in 1931 in Karachi, Kartar Lalvani's father was the owner of pharmacies in Karachi, Sind, present-day Pakistan. After the partition, his family moved to Bombay, where he was brought up. In 1957, he first came to London to study pharmacy, and thereafter he pursued his doctorate at the University of Bonn. Subsequently, his family immigrated to London during the 1960s.
Along with his brothers Gulu Lalvani and Pratap Lalvani he founded Binatone, which is currently run by Gulu's son Dino Lalvani. Binatone is named after Lalvani's youngest socialite sister Bina Ramani (née Lalvani). Kartar Lalvani, who served as an honorary professor at the University of Franche-Comté, is also a philanthropist, scholar and historian. He has written on the colonial history of India. His wife is a former Miss India and a Miss World runner-up.
Tej Lalvani, Kartar Lalvani's son and the current CEO of Vitabiotics Ltd., was born in 1974. Raised in Bangalore, India, he spent his childhood shutling between India and the UK, finally settling in London when he was 16. He earned a Bachelor's degree from Westminster Business School at the University of Westminster in 1996. In the early years of his career, he worked in the warehouse of Vitabiotics Ltd, before succeeding as the CEO.
Vitabiotics Supplements And Vitamins
Being the UK's largest vitamin company, Vitabiotics Ltd. has a wide range of specialist supplements for both men and women's health formulated by keeping in mind the demands of modern society. The company has developed a number of vitamins that target specific stages of life. It has a slew of multivitamins, which are the UK’s leading supplement brands and vitamin-enriched grooming products.
The company's products also include immune system vitamins and nutritional support for the immune system. It offers a comprehensive range of supplements designed to help support the immune function, with effective levels of key nutrients, such as vitamins D and C, selenium and zinc. Besides, it offers a wide range of vitamins for children to safeguard their health.
Vitabiotics Ltd's skin, hair and nails vitamins are well-known brands widely sold among beauty-conscious men and women. They have a therapeutic effect on internal health, besides skin, hair and nails. The ingredients in the vitamin, such as riboflavin, niacin and biotin, contribute to the maintenance of normal skin while selenium and zinc are beneficial for the maintenance of normal hair and nails.
Tej Lalvani
Over the last two decades, Tej Lalvani has led Vitabiotics Ltd. to new heights by growing it through strategic planning. He has extended its market to over a hundred countries. The family business now clocks over £300 million annually. It is renowned for producing many of the UK’s top quality vitamins, including Wellwoman, Perfectil, and Pregnacare. The company has bagged a slew of awards, including Boots’ Supplier of the Year and the Queen’s Award for Innovation.
Tej Lalvani has been involved in every aspect of Vitabiotics from the day he joined the organisation. After the completion of his education in pharmacy London, Germany and India, he worked in every department of the company, in order to gain an understanding of the functionalities of the company in depth. He started in a junior capacity and even drove the forklift trucks in the warehouse.
In the early years, Tej Lalvani developed a predilection for product design, branding and advertising. His involvement in these aspects of business continues even today, with nearly the entire marketing operations being managed by him. Besides the major marketing outdoors, print and TV campaigns through well-known celebrities, he has recently reoriented his business focus on digital channels. He has leveraged social media extensively to drive growth opportunities and engagement with millennials.
Thanks to Tej Lalvani's dedication and perseverance, Vitabiotics Ltd. has been taking big strides in business development. He was awarded ‘Young Entrepreneur of the Year' twice, first at the Asian Business Awards in 2012 and then at the TiE UK Awards 2013. He was ranked at number 48 on the GG2 Power List of the Most Influential Asian People in Britain. Also, he was featured on India Gazette London's The India-UK Power List 2017.
Besides, being the CEO of Vitabiotics Ltd., he also runs a property investment business in London along with his wife Tara Ruby. They have two children. Tej Lalvani is passionate about supporting vital educational campaigns and health awareness initiatives. Vitabiotics Ltd. has been supporting a number of charities, including Bliss, the charity that provides help to premature and sick babies, and Wellbeing of Women, dedicated to the health of women and babies across the UK. He is best known for being one of the 'dragons' on the BBC television series Dragons' Den from 2017 to 2021. In his spare time, aside from spending time with his family, he composes music and plays a couple of musical instruments.
No comments
Post a Comment